Cargando…

Schisandrin B Attenuates Cancer Invasion and Metastasis Via Inhibiting Epithelial-Mesenchymal Transition

BACKGROUND: Metastasis is the major cause of cancer related death and targeting the process of metastasis has been proposed as a strategy to combat cancer. Therefore, to develop candidate drugs that target the process of metastasis is very important. In the preliminary studies, we found that schisan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhen, Zhang, Biao, Liu, Kun, Ding, Zonghui, Hu, Xun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405072/ https://www.ncbi.nlm.nih.gov/pubmed/22848381 http://dx.doi.org/10.1371/journal.pone.0040480

Ejemplares similares

Expression of Concern: Schisandrin B Attenuates Cancer Invasion and Metastasis Via Inhibiting Epithelial-Mesenchymal Transition
Publicado: (2022)

Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial–mesenchymal transition inhibition
por: Li, Wei, et al.
Publicado: (2017)

High-dose vitamin C suppresses the invasion and metastasis of breast cancer cells via inhibiting epithelial-mesenchymal transition
por: Zeng, Ling-Hui, et al.
Publicado: (2019)

Small breast epithelial mucin promotes the invasion and metastasis of breast cancer cells via promoting epithelial-to-mesenchymal transition
por: Li, Qiu-Hua, et al.
Publicado: (2020)

Calpain inhibition attenuates bleomycin-induced pulmonary fibrosis via switching the development of epithelial-mesenchymal transition
por: Liu, Yuan, et al.
Publicado: (2018)

Schisandrin B inhibits epithelial-mesenchymal transition and stemness of large-cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF-κB and p38 MAPK signaling pathways
por: Li, Shuping, et al.
Publicado: (2021)

CDC27 Induces Metastasis and Invasion in Colorectal Cancer via the Promotion of Epithelial-To-Mesenchymal Transition
por: Qiu, Lin, et al.
Publicado: (2017)

Krüpple-like-factor 4 Attenuates Lung Fibrosis via Inhibiting Epithelial-mesenchymal Transition
por: Lin, Lianjun, et al.
Publicado: (2017)

Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition
por: Wang, Jun, et al.
Publicado: (2017)

Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness
por: Li, Xiao, et al.
Publicado: (2017)

Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis
por: Pearson, Gray W.
Publicado: (2019)

AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition
por: Yang, Liu, et al.
Publicado: (2018)

Schisandrin B attenuates pressure overload-induced cardiac remodeling in mice by inhibiting the MAPK signaling pathway
por: Ai, Fen, et al.
Publicado: (2019)

Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition
por: Gao, Yuan, et al.
Publicado: (2015)

USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4
por: Li, Yongmin, et al.
Publicado: (2017)

Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition
por: Kyung, Sun Young, et al.
Publicado: (2018)

Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer
por: Wang, Biao, et al.
Publicado: (2017)

miR-137 Inhibition of the Invasion, Metastasis, and Epithelial-Mesenchymal Transition of Nasopharyngeal Cancer by Regulating KDM1A
por: Lu, Han-qiang, et al.
Publicado: (2021)

Plasmodium infection prevents recurrence and metastasis of hepatocellular carcinoma possibly via inhibition of the epithelial-mesenchymal transition
por: Liang, Yun, et al.
Publicado: (2021)

FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition
por: Dong, Tianxiu, et al.
Publicado: (2016)

MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer
por: Li, Jiazhi, et al.
Publicado: (2018)

RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition()()
por: Dinglin, Xiaoxiao, et al.
Publicado: (2017)

YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition
por: Hao, Hailong, et al.
Publicado: (2021)

DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer
por: Chen, Xianliang, et al.
Publicado: (2015)

Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition
por: Garcia, Elizabeth, et al.
Publicado: (2021)

Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)

12-Lipoxygenase promotes invasion and metastasis of human gastric cancer cells via epithelial-mesenchymal transition
por: Zhong, Canmei, et al.
Publicado: (2018)

Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial–mesenchymal transition
por: Wang, Caihua, et al.
Publicado: (2019)

ASPP1 deficiency promotes epithelial-mesenchymal transition, invasion and metastasis in colorectal cancer
por: Liu, Dian, et al.
Publicado: (2020)

ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway
por: Ye, Jianxin, et al.
Publicado: (2017)

Withania somnifera Root Extract Inhibits Mammary Cancer Metastasis and Epithelial to Mesenchymal Transition
por: Yang, Zhen, et al.
Publicado: (2013)

The lnc‐CITED2‐2:1 inhibits metastasis via inhibiting CITED2 and epithelial‐mesenchymal transition in gallbladder cancer
por: Shen, Sheng, et al.
Publicado: (2020)

Alpha B‐crystallin promotes the invasion and metastasis of gastric cancer via NF‐κB‐induced epithelial‐mesenchymal transition
por: Chen, Dehu, et al.
Publicado: (2018)

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019)

Quercetin inhibits epithelial–mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial–mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells
por: Yu, Dinglai, et al.
Publicado: (2017)

The role of epithelial–mesenchymal transition programming in invasion and metastasis: a clinical perspective
por: Creighton, Chad J, et al.
Publicado: (2013)

Naringenin Decreases Invasiveness and Metastasis by Inhibiting TGF-β-Induced Epithelial to Mesenchymal Transition in Pancreatic Cancer Cells
por: Lou, Changjie, et al.
Publicado: (2012)

Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
por: Chang, Yu-Chan, et al.
Publicado: (2022)

Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition
por: Cui, Yuehong, et al.
Publicado: (2016)

Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway
por: Wang, Yifan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_agncqlgh288in7c74a1pn36qrf